Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will present and host investor meetings at the following conferences: 2020 Wells Fargo Virtual Healthcare Conference Date: Thursday, September 10, 2020 Analyst-hosted fireside chat: 4:00 PM ET H.C. Wainwright 22nd Annual Global Investment Conferenc